We speculate that IBD has alternative mechanisms to downregulate ApoC3 that does not affect triglycerides or that, in IBD, triglyceride metabolism is not completely regulated by ApoC3 or has other feedback pathways. Here, APOC3 is linked to inflammatory bowel disease.